Jupiter Neurosciences, Inc. Common Stock
Symbol: JUNS (NASDAQ)
1.44
▲ (3.60%) 0.050
Company Description:
Jupiter Neurosciences Inc is a clinical-stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a resveratrol platform product that targets the treatment of neuro-inflammation. Its platform product, JOTROL, offers potential therapeutic benefit to the majority of central nervous system diseases such as Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases.
Key Stats
- Today's Open: $1.39
- Today's High: $1.505
- Today's Low: $1.351
- Today's Volume: 107.26K
- Yesterday Close: $1.39
- Yesterday High: $1.4
- Yesterday Low: $1.22
- Yesterday Volume: 96.33K
- Last Min Volume: 80
- Last Min High: $1.44
- Last Min Low: $1.44
- Last Min VWAP: $1.44
Company Profile
- Name: Jupiter Neurosciences, Inc. Common Stock
- Website: https://www.jupiterneurosciences.com
- Listed Date: 2024-12-03
- Location: JUPITER, FL
- Market Status: Active
- CIK Number: 0001679628
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $44.59M
- Round Lot: 100
- Outstanding Shares: 34.83M
- Asset Type: CS
RECENT FILINGS FOR JUNS
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-19 | 10-Q | View |
| 2025-08-14 | NT 10-Q | View |
| 2025-07-10 | 8-K | View |
| 2025-07-09 | 8-K | View |
| 2025-07-07 | 4 | View |
| 2025-07-07 | 4 | View |
| 2025-07-03 | 4 | View |
| 2025-07-03 | 4 | View |
| 2025-07-01 | 4 | View |
| 2025-07-01 | 4 | View |
| 2025-05-15 | 10-Q | View |
| 2025-04-21 | 8-K | View |
| 2025-03-28 | 10-K | View |
| 2025-03-25 | 8-K | View |
| 2025-01-24 | 4 | View |
| 2025-01-24 | 4 | View |
| 2024-12-23 | 10-Q | View |
| 2024-12-20 | 8-K | View |
| 2024-12-19 | 8-K | View |
| 2024-12-04 | 8-K | View |
Latest News on JUNS